Electromed, Inc.

$ 38.68 4.15 %

Electromed, Inc. is engaged in the creation, production, and sale of respiratory therapy devices. Their focus is on delivering airway clearance through High Frequency Chest Wall Oscillation (HFCWO) technology, aiding pulmonary care for individuals of all ages across the United States and globally. The company's key offering is the SmartVest airway clearance system. This includes the SmartVest SQL System, an innovative solution comprising an inflatable therapy garment, a customizable air pulse generator, and a distinctive single-hose design for air delivery. They also provide SmartVest Connect, a wireless platform enabling personalized HFCWO therapy management for patients with diminished lung function. For acute care settings, Electromed supplies single-use SmartVest and SmartVest Wrap products to healthcare providers. Electromed's primary market is home healthcare, catering to patients diagnosed with conditions such as bronchiectasis, cystic fibrosis, and neuromuscular disease. The company distributes its products via medical professionals, healthcare facilities, and directly to consumers. Established in 1992, Electromed, Inc. is based in New Prague, Minnesota.

CEO: James L. Cunniff - https://smartvest.com

Price objectif

$38 -1.76 %

Recommandation

Buy

DCF

$ 60.72

Loading data...

ELMD vs S&P500

Loading data...

No data available.

Quick ratio

4.59

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

33.06

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

1.17

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

22.14 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

20.11 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

6.69

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.00

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

1.25

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
22.00 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
1.66 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.00 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.